Impact News +++ Transactions in connection with share buy-back programme 26-31 March 2026 (Cision) +++ VESTAS Aktie -3,50%

NANOVIRICIDES Aktie

>NANOVIRICIDES Aktienkurs

0.793 EUR (TradegateBSX)

Ask: 0.81 EUR / 2482 Stück

Bid: 0.775 EUR / 2609 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>NANOVIRICIDES Performance

1 Woche: -3,3%

1 Monat: -6,5%

3 Monate: -19,7%

6 Monate: -34,3%

1 Jahr: -27,1%

laufendes Jahr: -19,7%

>NANOVIRICIDES Aktie

Name:

NANOVIRICIDES NEW DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US6300873022 / A2PSNF

Symbol/ Ticker:

NV3P (Frankfurt)

Kürzel:

FRA:NV3P, ETR:NV3P, NV3P:GR

Index:

Webseite:

https://www.nanoviricides..

Profil:

Nanoviricides Inc. is a pioneering biotechnology company that focuses on the development of therapeutics to combat viral infections using nanotechnology. The company is dedicated to creating antiviral nanomedicine known as "nanoviricides," which are ..
>Volltext..

Marktkapitalisierung:

16.24 Mio. EUR

Unternehmenswert:

11.9 Mio. EUR

Umsatz:

EBITDA:

-6.72 Mio. EUR

Nettogewinn:

-7.19 Mio. EUR

Gewinn je Aktie:

-0.42 EUR

Schulden:

Liquide Mittel:

4.45 Mio. EUR

Operativer Cashflow:

-6.34 Mio. EUR

Bargeldquote:

4.31

Umsatzwachstum:

Gewinnwachstum:

21.71%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

NANOVIRICIDES

Letzte Datenerhebung:

01.04.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 21.6 Mio. St.

Frei handelbar: 97.22%

Leerverk. Aktien: -

Rückkaufquote: -45.9%

Mitarbeiter: 7

Umsatz/Mitarb.: -

Analysten:

Analystenrating: No rating

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: 2.22

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -69.79%

Eigenkaprendite: -77.53%

>Peer Group

Gesundheit

>NANOVIRICIDES Chart & Kurs - Tradegate

>NANOVIRICIDES News

11.03.26 - 13:42	NanoViricides Presenting at NIBA′s 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete (Accesswire)
	SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cann......

22.02.26 - 08:12	NanoViricides CEO discusses progress of broad-spectrum antiviral candidate NV-387 - ICYMI (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

21.02.26 - 19:00	NanoViricides CEO discusses progress of broad-spectrum antiviral candidate NV-387 - ICYMI (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

20.02.26 - 03:12	NanoViricides advances toward fully funded Phase II MPox trial in DRC (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

19.02.26 - 23:36	NanoViricides advances broad-spectrum antiviral NV-387 towards Phase II MPox study (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

13.02.26 - 09:24	Small cap wrap: BioVie, VivoPower, NanoViricides, Aftermath Silver... (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 14:42	MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the......

10.02.26 - 14:42	Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the......

02.02.26 - 14:42	NanoViricides President Dr. Diwan Interviewed by Mission Matters′ Adam Torres (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs......

20.01.26 - 14:06	DealFlow Events: NanoViricides to Present at the 3rd Annual DealFlow Discovery Conference (Accesswire)
	SHELTON, CT / ACCESS Newswire / January 20, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the vi......

13.01.26 - 19:00	NanoViricides highlights need for broad-spectrum antivirals amid severe flu season (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

13.01.26 - 14:42	NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2 (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs......

12.01.26 - 05:00	After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers (RTTNews)
	Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates....

18.12.25 - 06:36	Small cap wrap: Tiziana Life Sciences, NanoViricides, 1911 Gold, Protalix BioTherapeutics… (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

18.12.25 - 06:36	NanoViricides advances Phase 2 trials for broad-spectrum antiviral NV-378 in $17B market: analysts (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

01.12.25 - 14:42	NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the dev......

17.11.25 - 15:03	NanoViricides GAAP EPS of -$0.10 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

17.11.25 - 14:42	NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarte......

14.11.25 - 14:42	NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2 (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drug......

12.11.25 - 23:06	NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close (Accesswire)
	SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase ag......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Es gibt einen Tag, um geboren zu werden, und einen Tag, um zu sterben. - China Weisheit

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram